Compare Invesco DB Oil Fund (DBO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Oil Fund vs State Street SPDR S&P Biotech ETF — how do they compare? Invesco DB Oil Fund trades at $20.98, while State Street SPDR S&P Biotech ETF trades at $159.21. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Invesco DB Oil Fund nearer its low. Which is the better fit depends on your goals.
| DBO | XBI | |
|---|---|---|
Sector | Commodities - Energy | Broad Market / Factor |
52-Week High | $23.80 | $164.28 |
52-Week Low | $11.98 | $86.92 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBO trades at $20.99, up 0.67% today, with a bullish technical signal from moving averages. The stock shows neutral oscillators but faces uniform support and resistance at $21. Recent news highlights oil market volatility due to Middle East tensions and OPEC demand forecast cuts, influencing energy sector sentiment.
The outlook is clouded by supply disruptions and demand uncertainty, posing risks for energy stocks. Investment appeal hinges on oil price stability and company-specific fundamentals, which require verification from recent SEC filings and earnings reports for a complete assessment.
XBI, the SPDR S&P Biotech ETF, trades at $159.39, up 0.86% on the day, with a bullish technical signal driven by moving averages. The fund holds 155 biotech stocks, benefiting from strong sector momentum, including a 17% gain in June 2026 (ETF Trends, 2026-07-01). Recent news highlights institutional buying and positive drug trial outcomes fueling the rally.
Outlook: Biotech sector tailwinds from M&A, AI drug discovery, and clinical successes support further upside, but high volatility and policy risks persist. Investors gain diversified exposure to small- and mid-cap biotech innovation, though the 0.35% expense ratio and lack of dividend yield may deter income-focused buyers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Invesco DB Oil Fund
DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
